Clinical effects of Yiqi Huoluo Mingmu Decoction combined with Conbercept Ophthalmic Injection on patients with non-proliferative diabetic retinopathy
10.3969/j.issn.1001-1528.2024.07.017
- VernacularTitle:益气活络明目汤联合康柏西普眼用注射液对非增殖期糖尿病视网膜病变患者的临床疗效
- Author:
Chun-De TAO
1
;
Yu-Pei FENG
;
Zhuo-Lin XIE
Author Information
1. 甘肃省武威市中医医院眼科,甘肃 武威 733000
- Keywords:
Yiqi Huoluluo Mingmu Decoction;
Conbercept Ophthalmic Injection;
non-proliferative diabetic retinopathy
- From:
Chinese Traditional Patent Medicine
2024;46(7):2230-2234
- CountryChina
- Language:Chinese
-
Abstract:
AIM To explore the clinical effects of Yiqi Huoluluo Mingmu Decoction combined with Conbercept Ophthalmic Injection on patients with non-proliferative diabetic retinopathy.METHODS One hundred and sixty-seven patients were randomly assigned into control group(83 cases)for administration of Conbercept Ophthalmic Injection,and observation group(84 cases)for administration of both Yiqi Huoluluo Mingmu Decoction and Conbercept Ophthalmic Injection.The changes in clinical effects,miR-15b,CTGF,VEGF,hemodynamic indices(PSV,EDV,RI),visual field gray value,CMT,hemangioma count,blood spot area,BCVA,electroretinograms(amplitudes of a wave,b wave under light-dark adaptation),TCM symptom scores and incidence of adverse reactions were detected.RESULTS The observation group demonstrated higher total effective rate than the control group(P＜0.05).After the treatment,the two groups displayed increased miR-15b,PSV,EDV,BCVA,electroretinograms(P＜0.05),and increased CTGF,VEGF,RI,visual field gray value,CMT,hemangioma count,blood spot area,TCM symptom scores(P＜0.05),especially for the observation group(P＜0.05).No significant difference in incidence of adverse reactions was found between the two groups(P＞0.05).CONCLUSION For the patients with non-proliferative diabetic retinopathy,Yiqi Huoluluo Mingmu Decoction combined with Conbercept Ophthalmic Injection can improve hemodynamics,reduce fundus lesions,and regulate miR-15b,VEGF expressions.
